Advertisement
Australia markets closed
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • AUD/USD

    0.6540
    +0.0017 (+0.26%)
     
  • OIL

    83.75
    +0.18 (+0.22%)
     
  • GOLD

    2,352.30
    +9.80 (+0.42%)
     
  • Bitcoin AUD

    97,934.61
    -956.60 (-0.97%)
     
  • CMC Crypto 200

    1,333.81
    -62.73 (-4.49%)
     
  • AUD/EUR

    0.6107
    +0.0034 (+0.56%)
     
  • AUD/NZD

    1.0994
    +0.0037 (+0.33%)
     
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NASDAQ

    17,737.44
    +306.94 (+1.76%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • Dow Jones

    38,307.04
    +221.24 (+0.58%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

Why Shares of Anavex Life Sciences Rose 12.4% in February

Why Shares of Anavex Life Sciences Rose 12.4% in February

Shares of Anavex Life Sciences (NASDAQ: AVXL) rose 12.4% in February, according to data provided by S&P Global Market Intelligence. The clinical-stage biotech's stock closed at $10.87 in January, then rose to a high of $11.93 on Feb. 7, the day the company announced first-quarter earnings. The stock closed the month at $9.52.